Meeting
2022 ASCO Genitourinary Cancers Symposium
Real-world evidence of patient-reported outcomes following definitive radiation therapy for prostate cancer: Findings from an Australian population-based clinical outcomes registry.
Authors
Wee Loon Ong
Alfred Health Radiation Oncology, Melbourne, VIC, Australia
Wee Loon Ong , Melanie Evans , Nathan Papa , Jeremy Laurence Millar
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Symptoms, Toxicities, Patient-Reported Outcomes, and Whole-Person Care
Citation
J Clin Oncol 40, 2022 (suppl 6; abstr 244)
DOI
10.1200/JCO.2022.40.6_suppl.244
Abstract #
244
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Real-world clinical outcomes of patients with localized prostate cancer (LPC) treated with external beam radiation therapy (EBRT).
First Author: Lawrence Ivan Karsh
Poster
2024 ASCO Genitourinary Cancers Symposium
Clinical and patient-reported outcomes of fully adaptive MR-guided stereotactic radiotherapy to prostate: Real-world experience from the UK.
First Author: Prantik Das
Poster
2023 ASCO Annual Meeting
Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data.
First Author: Dina Elantably
Poster
2023 ASCO Genitourinary Cancers Symposium
Real world prospective evaluation of clinical outcomes in patients with non-metastatic castrate resistant prostate cancer treated with darolutamide.
First Author: Amarnath Challapalli